Benzinga | Nov 10, 2021 06:43PM EST

DiaMedica Therapeutics Q3 EPS $(0.18) Beats $(0.23) Estimate

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 5.26 percent increase over losses of $(0.19) per share from the same period last year.